{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:39:53Z","timestamp":1778830793778,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.parkreldis.2024.106971","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T02:50:40Z","timestamp":1712631040000},"page":"106971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6369-1203","authenticated-orcid":false,"given":"Robert A.","family":"Hauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-1516","authenticated-orcid":false,"given":"Aleksandar","family":"Videnovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcio","family":"Soares-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2581-4891","authenticated-orcid":false,"given":"Grace S.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-2403","authenticated-orcid":false,"given":"Eric","family":"Jen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Francisco","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Klepitskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.parkreldis.2024.106971_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.870050404","article-title":"Sleep disorders and sleep effect in Parkinson's disease","volume":"5","author":"Factor","year":"1990","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.106971_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2024.106971_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.870130606","article-title":"A community-based study of sleep disorders in patients with Parkinson's disease","volume":"13","author":"Tandberg","year":"1998","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106971_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/smrv.2002.0229","article-title":"Parkinson's disease and sleep","volume":"7","author":"Garcia-Borreguero","year":"2003","journal-title":"Sleep Med. Rev."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106971_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ncpneuro0775","article-title":"Sleep disturbances in patients with parkinsonism","volume":"4","author":"De Cock","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106971_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ageing\/afj087","article-title":"Sleep-related problems of Parkinson's disease","volume":"35","author":"Dhawan","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.parkreldis.2024.106971_bib7","article-title":"Circadian and sleep dysfunctions in neurodegenerative disorders-an update","volume":"14","author":"Fifel","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106971_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2012.08.018","article-title":"Circadian and sleep disorders in Parkinson's disease","volume":"243","author":"Videnovic","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2024.106971_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/NSS.S18897","article-title":"Sleep disturbances in Parkinson's disease patients and management options","volume":"3","author":"Claassen","year":"2011","journal-title":"Nat. Sci. Sleep"},{"issue":"24","key":"10.1016\/j.parkreldis.2024.106971_bib10","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.4103\/0366-6999.247210","article-title":"Management recommendations on sleep disturbance of patients with Parkinson's disease","volume":"131","author":"Liu","year":"2018","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106971_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41386-019-0448-y","article-title":"Sleep in Parkinson's disease","volume":"45","author":"Stefani","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106971_bib12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jnnp-2017-316136","article-title":"Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study","volume":"88","author":"Suzuki","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106971_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.10167","article-title":"Sleep disorders in Parkinson's disease","volume":"17","author":"Kumar","year":"2002","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106971_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1468-1331.2007.01998.x","article-title":"The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease","volume":"15","author":"Porter","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2024.106971_bib15","article-title":"Opicapone pharmacokinetics and effects on COMT activity and levodopa pharmacokinetics in patients with Parkinson's disease receiving carbidopa\/levodopa","author":"LeWitt","year":"2022","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2024.106971_bib16","series-title":"Poster Presented at the 25th Annual International Congress of Parkinson's Disease and Movement Disorders, Virtual","article-title":"Effects of once-daily opicapone 50 mg on the pharmacokinetics of levodopa administered as carbidopa\/levodopa extended-release capsules: an open-label phase 1 study","author":"Loewen","year":"2021"},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106971_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1474-4422(15)00336-1","article-title":"Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial","volume":"15","author":"Ferreira","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106971_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamaneurol.2016.4703","article-title":"Opicapone as adjunct to levodopa therapy in patients with Parkinson disease and motor fluctuations: a randomized clinical trial","volume":"74","author":"Lees","year":"2017","journal-title":"JAMA Neurol."},{"issue":"21","key":"10.1016\/j.parkreldis.2024.106971_bib19","doi-asserted-by":"crossref","first-page":"e1849","DOI":"10.1212\/WNL.0000000000005557","article-title":"Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease","volume":"90","author":"Ferreira","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106971_bib20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/mds.20248","article-title":"Parkinson's disease home diary: further validation and implications for clinical trials","volume":"19","author":"Hauser","year":"2004","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106971_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002826-200003000-00003","article-title":"A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia","volume":"23","author":"Hauser","year":"2000","journal-title":"Clin. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.106971_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/ene.13914","article-title":"Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions","volume":"26","author":"Ferreira","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2024.106971_bib23","series-title":"Prescribing Information","year":"2020"},{"key":"10.1016\/j.parkreldis.2024.106971_bib24","series-title":"Sinemet [prescribing Information]","year":"2018"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106971_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40035-020-00187-1","article-title":"Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study","volume":"9","author":"Reichmann","year":"2020","journal-title":"Transl. Neurodegener."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024009830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024009830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T08:32:01Z","timestamp":1717317121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024009830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":25,"alternative-id":["S1353802024009830"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106971","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106971"}}